The groundbreaking approach of this peptide represents a significant development in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and the GIP https://tirzepatide-peptide622405.luwebs.com/42973298/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment